CYCLO THERAPEUTICS INC
NASDAQ: CYTHW (Cyclo Therapeutics, Inc.)
Kemas kini terakhir: semalam, 11:59AM0.032
0.00 (0.00%)
| Penutupan Terdahulu | 0.032 |
| Jumlah Dagangan | 28,412 |
| Purata Dagangan (3B) | 12,317 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -3,545.95% |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -52.80% |
| Nisbah Semasa (MRQ) | 0.170 |
| Aliran Tunai Operasi (OCF TTM) | -22.52 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -13.05 M |
| Pulangan Atas Aset (ROA TTM) | -284.27% |
AISkor Stockmoo
| Nilai 60% | -5.0 |
| Keuntungan lemah. Kecairan jangka pendek nipis. Aliran tunai negatif. info | |
| Daripada penilaian laporan AI Insight kami tentang pulangan dijangka berbanding risiko. info | NA |
| Penilaian Relatif info | NA |
| Pertumbuhan Tersirat info | NA |
| Sejarah Penilaian info | NA |
| Pulangan atas Modal info | NA |
| Trend Perolehan info | NA |
| Nilai Pegangan info | NA |
| Premium Risiko info | NA |
| Penilaian Pasaran info | NA |
| Masa | NA |
| Daripada analisis teknikal AI kami terhadap carta. info | NA |
| Kekuatan Aliran info | NA |
| Persediaan Teknikal info | NA |
| Corak Lilin info | NA |
| Aliran Jangka Sederhana info | NA |
| Sentimen 40% | 0.0 |
| Tiada harga sasaran terkini, jadi berdasarkan arah semakan harga sasaran. info | |
| Sentimen Pegangan info | NA |
| Sentimen Berita info | NA |
| Wang Pintar | NA |
| Aktiviti Orang Dalam info | NA |
| Aliran Institusi info | NA |
| Kedudukan Jual Singkat info | NA |
| Keadaan pasaran dan sektor lemah. | |
| Persekitaran pasaran berhati-hati. info | |
| Sektor mengatasi prestasi pasaran. | |
| Hanya satu tonggak mempunyai bacaan yang jelas, jadi skor tidak berubah. | |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | NA |
| Tiada aliran jelas bagi jangka pendek, sederhana dan panjang. info | |
| Tiada isyarat jelas daripada sokongan dan rintangan. info | |
| Skor Akhir | -3.14 |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Cyclo Therapeutics, Inc. | - | - |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B | Skor |
|---|---|---|---|---|---|
| CYTHW | - | - | - | - | -3.1 |
| ZYBT | 72 M | - | - | 2.13 | -1.7 |
| SHPH | 17 M | - | - | 0.200 | -2.4 |
| CANB | 2 M | - | 0.233 | 33.49 | -1.4 |
| BIOA | - | - | - | 0.680 | -1.9 |
| CLVRW | - | - | - | - | -0.1 |
|
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of neurodegenerative diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo that is in Phase IIb clinical trials for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |